Screener
Integra LifeSciences IART Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $4,482 | $(484,073) | $(134) | $(509,366) |
| Net income (loss) per share | ||||
| Basic | $0.06 | $(6.31) | — | $(6.65) |
| Diluted | $0.06 | $(6.31) | — | $(6.65) |
| Weighted average common shares outstanding (See Note 12): | ||||
| Basic | 77,293 | 76,695 | 77,122 | 76,579 |
| Diluted | 78,168 | 76,695 | 77,122 | 76,579 |
| Comprehensive loss (See Note 13) | (4,775) | (490,874) | (10,254) | $(512,702) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's comprehensive income (loss), net of tax, attributable to parent?
- Integra LifeSciences (IART) reported comprehensive income (loss), net of tax, attributable to parent of -$4.78M in Q2 2026.
- How has Integra LifeSciences's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Integra LifeSciences's comprehensive income (loss), net of tax, attributable to parent increased by 99.0% year-over-year, from -$490.87M to -$4.78M.
Ask your AI about Integra LifeSciences's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude